Altimmune: Updated Data Supports Pemvidutide's 'Market Disruptor' Prospects
Pemvidutide's potential in obesity and MASH, combined with lean mass preservation, could make it a market leader in the ...
Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today
The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.
Novo Nordisk Sinks on Obesity Drug Study's Disappointing Results
Key Takeaways Novo Nordisk's U.S.-listed shares lost ground Friday after a Phase 2a trial of the pharmaceutical firm’s latest ...
Yahoo Finance23h
Stone Ridge 2053 Inflation-Protected Longevity Income ETF (LIAJ)
Novo Nordisk (NVO) stock is falling Friday morning after the pharmaceutical ... Shares of FedEx (FDX) are plummeting in after-hours trading. The shipping giant reported first quarter adjusted earnings ...